Company: MBVI
Filing Date: 2025-08-18
Form Type: S-1/A
Source: 0001213900-25-078000
Chunk: 59

Company: M3-Brigade Acquisition VI Corp.
Filing Date: 2025-08-18
Form: S-1/A
Chunk 59
---
 independent directors as and when required by the rules of Nasdaq and Rule 10A of the Exchange Act. Among its responsibilities, the audit committee will review on a quarterly basis all payments that were made to our sponsor, officers or directors, or our or their affiliates and monitor compliance with the other terms relating to this offering. If any noncompliance is identified, then the audit committee will be charged with the responsibility to promptly take all action necessary to rectify such noncompliance or otherwise to cause compliance with the terms of this offering. For more information, see the section entitled “Management — Committees of the Board of Directors — Audit Committee.” |

42

| Conflicts of Interest: |     | We are not prohibited from pursuing an initial business combination with a company that is affiliated with our sponsor, our officers or directors, the Sponsor Manager or the non-managing sponsor investors, or completing the business combination through a joint venture or other form of shared ownership with our sponsor, our officers or directors, the Sponsor Manager or the non-managing sponsor investors. In the event we seek to complete an initial business combination with a target that is affiliated (as defined in our amended and restated memorandum and articles of association) with our sponsor, officers or directors, we, or a committee of independent directors, would obtain an opinion from an independent investment banking firm that is a member of FINRA or a valuation or appraisal firm stating that the consideration to be paid by us in such an initial business combination is fair to our company from a financial point of view. We are not required to obtain such an opinion in any other context.                                                                                                                                                                                              
 Our sponsor, members of our management team and our directors will directly or indirectly own founder shares and/or private placement warrants following this offering and, accordingly, members of our management team and our directors may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. The low price that our sponsor paid for the founder shares creates an incentive whereby members of our management team and our directors could potentially make a substantial profit even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders. If we are unable to complete our initial business combination within the completion window, the founder shares and private placement warrants may expire worthless, except to the extent they receive liquidating distributions from assets outside the trust account, which could create an incentive for our sponsor, executive officers and directors to complete a transaction even if we select an acquisition target that subsequently declines